News Guidelines 👤 Member Login 🔒 Staff Login
Denials & Appeals

Immunosuppressive drugs: CMS compliance tip to prevent claim denials (documentation, 90-day supply, coverage rules)

· Review time: 5 min · Source: CMS MLN Provider Compliance Tips (featured in MLN Connects
  • CMS reports a 23.2% improper payment rate ($45.4M projected) for immunosuppressive drugs in the 2024 reporting period; insufficient documentation (40.3%) and no documentation (15.1%) were the top reasons.
  • Coverage under DMEPOS requires a Medicare-covered organ transplant, Part A at the time of transplant and Part B when drugs are dispensed (see LCD L33824 and Article A52474).
  • "Immunosuppressive drug claims require dosage, frequency, and administration route."
  • "We limit the quantity of immunosuppressive drugs dispensed to a 90-day supply, effective January 1, 2025." Bill recurring items on prospective, not retrospective, use.
  • Source: CMS MLN Provider Compliance Tips (featured in MLN Connects, Nov 19, 2026) — cms.gov/training-education/medicare-learning-networkr-mln/co…

Summarised by the LinkupRCM team for coders, billers and RCM professionals. Have a question about this? Ask in the LinkupRCM community forum.